ReviewThe Journal of pathology2026

Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?

Giuseppe Schepisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.